Modification of lincomycin.
D000215:Acylation; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002208:Caproates / Q000627:therapeutic use; D002254:Carbonates / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002981:Clindamycin / Q000378:metabolism / Q000627:therapeutic use; D004952:Esters / Q000627:therapeutic use; D000882:Haplorhini; D006801:Humans; D006868:Hydrolysis; D008034:Lincomycin / Q000138:chemical synthesis / Q000378:metabolism / Q000627:therapeutic use; D051379:Mice; D010710:Phosphates / Q000627:therapeutic use; D013045:Species Specificity; D013302:Streptomyces / Q000378:metabolism; D013454:Sulfoxides / Q000096:biosynthesis
D002208:Caproates; D002254:Carbonates; D004952:Esters; D010710:Phosphates; D013454:Sulfoxides; D002981:Clindamycin; D008034:Lincomycin